COVID-19: DCGI nod to SII for phase 2 and 3 human clinical trials of Oxford vaccine candidate

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa READ MORE